- From 2022 onward, a further 7 to 9 billion doses of vaccines are necessary annually to keep (re-) infection rates low
Dubai: Global logistics leader DHL has released a white paper highlighting its learnings from one year of fighting the pandemic and how to prepare to handle public health emergencies in the future. “Revisiting Pandemic Resilience” examines the role played by logistics and supply chain management in handling the largest global health crisis in more than 100 years.
DHL has played a vital role in the fight against the virus since the beginning; ensuring the availability and distribution of medicines and medical supplies, test kits, ancillary supplies, treatments, and personal protective equipment (PPE). DHL’s Global Humanitarian Logistics Competence Center in Dubai coordinated the movement of aid and relief for needy communities on behalf of humanitarian organizations.
In the past 4 months, DHL has distributed over 200 million doses of all approved vaccines to over 120 countries through 9,000 operated flights, with more than 350 DHL facilities involved. Over 50 bilateral and multilateral collaborations with partners in both the pharma and public sector and several new dedicated services were created to stem this task.
Thomas Ellmann, Vice President, Life Sciences & Healthcare and Head of Clinical Trials Logistics at DHL Customer Solutions & Innovation, said: “The past one year has highlighted the importance of logistics and supply chain management to manage the pandemic, ensure business continuity and protect public health. It has also shown us that together we are stronger. Multisectoral partnerships enabled vaccine distribution at unprecedented speed.”
According to the DHL white paper, the past one year witnessed important achievements across research and development, production, and supply chain management as well as policy; chief among them being a vaccine developed five times faster than any other vaccine in history. Production was ramped up in record time – quadrupling pre-COVID vaccine production capacities, while logistics rolled the distribution three times faster than usual, building unprecedented cold chains with stringent temperatures of up to - 70°C.
An unprecedented level of multisector, international collaboration – including logistics and pharma companies as well as the public health and military infrastructures of many governments – has been a key driver in the fight against COVID-19. HOPE Consortium, the UAE-based public-private partnership coordinated the safe and efficient international distribution of billions of doses of COVID-19 vaccines, with the help of commercial partners such as DHL to expand its global reach and strengthen logistical solutions. Logistics couriers were allowed to transport vaccine doses on military helicopters or boats to avoid traffic jams and speed up delivery.
Katja Busch, Chief Commercial Officer DHL & Head of DHL Customer Solutions & Innovation, added: “The UAE’s significant investments in creating robust air, sea and land infrastructure facilitated logistics and vaccine distribution, helping us keep supply chains resilient. While the race against the virus continues, leveraging the power of such collaborations and data analytics will be key. We need to remain prepared for high patient and vaccine volumes, maintain logistics infrastructure and capacity, while planning for seasonal fluctuations by providing a stable and well-equipped platform for the years to come.”
It is estimated around 10 billion vaccine doses are required globally by end of 2021. While the UAE and Bahrain have some of the highest per-capita rates of immunization in the world, less-developed infrastructure in other countries has made the vaccine rollout challenging. The UAE set up storage facilities with the capacity for millions of vials to cover its own domestic demand as well as to stockpile the vaccine for countries that lack adequate storage. The UAE’s humanitarian efforts throughout the pandemic have been enabled by successful partnerships between super connectors such as Emirates and logistics leaders such as DHL.
In 2022-2023, around 7-9 billion additional doses of vaccines annually will be necessary to keep (re-) infection rates low and slow down the pace of virus mutations. The COVID-19 pandemic is a dynamic situation, as is the virus that causes it. It is not only imperative to vaccinate the world as quickly as possible, but to ensure immunization is sustained in the years to come. As a result, the COVID-19 supply chain and logistics setup in 2021 will remain important going forward.
DHL – The logistics company for the world
DHL is the leading global brand in the logistics industry. Our DHL divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management. With about 400,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialized solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing & energy, auto-mobility and retail, DHL is decisively positioned as “The logistics company for the world”.
DHL is part of Deutsche Post DHL Group. The Group generated revenues of more than 66 billion euros in 2020. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. Deutsche Post DHL Group aims to achieve zero- emissions logistics by 2050.
+971 4 506 5555
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.